Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preservative-free vs Preserved Eye Drops After Cataract Surgery
NCT04050644Phase 4Recruiting
- Sponsor
- UZ Leuven
- Start
- Oct 2018
- Primary completion
- Jun 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of dexamethasone and diclofenac in cataract (2 arms), sponsored by UZ Leuven. Primary endpoint: Aqueous flare value at 4 weeks. Started Oct 2018; status: recruiting.
02
Drugs
dexamethasonediclofenac
03
Conditions
cataract
Beyond the preview
Go deeper on NCT04050644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04050644.